Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Heartseed, Inc.

219A.TJPX
Healthcare
Medical - Pharmaceuticals
¥1872.00
¥-35.00(-1.84%)
Japanese Market opens in 17h 27m

Heartseed, Inc. Fundamental Analysis

Heartseed, Inc. (219A.T) shows weak financial fundamentals with a PE ratio of 71.08, profit margin of 19.58%, and ROE of 8.31%. The company generates $3.1B in annual revenue with weak year-over-year growth of 1.53%.

Key Strengths

Operating Margin24.00%
Cash Position17.43%
Current Ratio18.48

Areas of Concern

ROE8.31%
PEG Ratio5.39
We analyze 219A.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 88.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
88.0/100

We analyze 219A.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

219A.T struggles to generate sufficient returns from assets.

ROA > 10%
7.28%

Valuation Score

Weak

219A.T trades at a premium to fair value.

PE < 25
71.08
PEG Ratio < 2
5.39

Growth Score

Moderate

219A.T shows steady but slowing expansion.

Revenue Growth > 5%
1.53%
EPS Growth > 10%
44.84%

Financial Health Score

Excellent

219A.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
18.48

Profitability Score

Moderate

219A.T maintains healthy but balanced margins.

ROE > 15%
8.31%
Net Margin ≥ 15%
19.58%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 219A.T Expensive or Cheap?

P/E Ratio

219A.T trades at 71.08 times earnings. This suggests a premium valuation.

71.08

PEG Ratio

When adjusting for growth, 219A.T's PEG of 5.39 indicates potential overvaluation.

5.39

Price to Book

The market values Heartseed, Inc. at 5.56 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.56

EV/EBITDA

Enterprise value stands at 68.58 times EBITDA. This signals the market has high growth expectations.

68.58

How Well Does 219A.T Make Money?

Net Profit Margin

For every $100 in sales, Heartseed, Inc. keeps $19.58 as profit after all expenses.

19.58%

Operating Margin

Core operations generate 24.00 in profit for every $100 in revenue, before interest and taxes.

24.00%

ROE

Management delivers $8.31 in profit for every $100 of shareholder equity.

8.31%

ROA

Heartseed, Inc. generates $7.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.28%

Following the Money - Real Cash Generation

Operating Cash Flow

Heartseed, Inc. generates strong operating cash flow of $1.10B, reflecting robust business health.

$1.10B

Free Cash Flow

Heartseed, Inc. generates strong free cash flow of $1.07B, providing ample flexibility for dividends, buybacks, or growth.

$1.07B

FCF Per Share

Each share generates $46.76 in free cash annually.

$46.76

FCF Yield

219A.T converts 2.46% of its market value into free cash.

2.46%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

71.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

5.39

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.56

vs 25 benchmark

P/S Ratio

Price to sales ratio

14.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

18.48

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How 219A.T Stacks Against Its Sector Peers

Metric219A.T ValueSector AveragePerformance
P/E Ratio71.0828.25 Worse (Expensive)
ROE8.31%780.00% Weak
Net Margin19.58%-20122.00% (disorted) Strong
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio18.484.66 Strong Liquidity
ROA7.28%-14687.00% (disorted) Weak

219A.T outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Heartseed, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

73.25%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

43.06%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

30.83%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ